mutLBSgeneDB |
Gene summary for TOB1 |
Gene summary |
Basic gene Info. | Gene symbol | TOB1 |
Gene name | transducer of ERBB2, 1 | |
Synonyms | APRO6|PIG49|TOB|TROB|TROB1 | |
Cytomap | UCSC genome browser: 17q21 | |
Type of gene | protein-coding | |
RefGenes | NM_001243877.1, NM_001243885.1,NM_005749.3, | |
Description | proliferation-inducing gene 49protein Tob1transducer of erbB-2 1 | |
Modification date | 20141207 | |
dbXrefs | MIM : 605523 | |
HGNC : HGNC | ||
Ensembl : ENSG00000141232 | ||
HPRD : 09273 | ||
Vega : OTTHUMG00000162277 | ||
Protein | UniProt: P50616 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_TOB1 | |
BioGPS: 10140 | ||
Pathway | NCI Pathway Interaction Database: TOB1 | |
KEGG: TOB1 | ||
REACTOME: TOB1 | ||
Pathway Commons: TOB1 | ||
Context | iHOP: TOB1 | |
ligand binding site mutation search in PubMed: TOB1 | ||
UCL Cancer Institute: TOB1 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0008285 | negative regulation of cell proliferation | 19276069 | GO:0017148 | negative regulation of translation | 23236473 | GO:0060212 | negative regulation of nuclear-transcribed mRNA poly(A) tail shortening | 18377426 | GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 21336257 | GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 21336257 |
Top |
Ligand binding site mutations for TOB1 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | P49 | K48R | COAD | 2 | P49 | K48E | COAD | 2 | W93,F97 | D95N | BLCA | 1 | P49 | K48N | COAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for TOB1 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | W93 | D95N | -1.2125003 | F97 | D95N | -1.2125003 | P49 | K48N | -1.151233 | P49 | K48R | -0.81157635 | P49 | K48E | -0.77910959 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for TOB1 from PDB |
PDB ID | PDB title | PDB structure | 2Z15 | Crystal structure of human Tob1 protein |
Top |
Differential gene expression and gene-gene network for TOB1 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for TOB1 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0263454 | Chloracne | 1 | Biomarker |
umls:C0014175 | Endometriosis | 1 | Biomarker |
umls:C0027659 | Neoplasms, Experimental | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for TOB1 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of TOB1 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | 549 | 1-(PROPAN-2-YL)-1H-BENZIMIDAZOLE-5-CARBOXYLIC ACID | 5ci9 | A | P49 F97 | 53Y | PYRROLO[1,2-A]QUINOXALIN-4(5H)-ONE | 5ci8 | A | W93 |
Top |
Conservation information for LBS of TOB1 |
Multiple alignments for P50616 in multiple species |
LBS | AA sequence | # species | Species |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |